from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1704c/cycA

LFCtreatmentdescriptionclass of inhibitor

-0.439

Amikacinug/mL Amikacintranslation

-0.321

Cap5-10ug/mL Capreomycintranslation

-1.365

Rox10-50 ug/mL Roxithromycintranslation

-0.418

SM2-5 ug/mL Streptomycintranslation

-1.822

Tet5-10 ug/mL Tetracyclinetranslation

0.446

Rif0.2-5ug/mL Rifampicintranscription

-0.199

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.322

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.952

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.511

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.053

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.059

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.323

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.143

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.147

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.056

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.218

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.052

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.174

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.041

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.236

KCN5-20 ug/mL Potassium cyaniderespiration

0.127

NaN30.2-2 mM Sodium aziderespiration

-0.040

Nigericin50 uM Nigericinrespiration

0.015

TRC10-150 ug/mL Triclosanrespiration

-1.367

TRZ10-25 ug/mL Thioridazinerespiration

-1.515

Valinomycin0.5-10 uM Valinomycinrespiration

0.290

ZnSO42 mM ZnSO4respiration

-0.037

menadione6-10 ug/mL Menadionerespiration

0.270

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.193

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.015

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.074

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.289

NRP_1Non-replicating persistence stage 1dosRassociated

-0.297

Amp0.2mg/mL AmpicillincellWall

0.163

Cephalexin20-100 ug/mL CephalexincellWall

0.387

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.273

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.018

EMB10-20 ug/mL EthambutolcellWall

-0.334

Eta12-40 ug/mL EthionamidecellWall

-0.482

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.019

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.187

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.083

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.408

BZA0.12 mg/mL BenzamidearomaticAmides

0.384

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.314

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.322

H2O24 mM hydrogen peroxideDNAdamaging

1.076

Levo10 ug/mL LevofloxacinDNAdamaging

0.989

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.225

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.197

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.875

UVUV-irradiationDNAdamaging

0.504

ARP41-4 ug/mL Antitubercular compound ARP4?

0.730

Antimycin12.5-50 ug/mL Antimycin A?

0.400

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.654

PA_110-50 ug/mL Antitubercular compound PA-1?

0.543

PA_2110-50 ug/mL Antitubercular compound PA-21?

-3.002

PA8240.2-2 ug/mL PA-824?

-0.768

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.181

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.285

Verapamil50 uM Verapamil?

0.366

mercaptoethanol2 mM 2-Mercaptoethanol?

0.307

methoxatin10-20 ug/mL Methoxatin?